Literature DB >> 6932908

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.

C G Potter, C Bunch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6932908      PMCID： PMC2010366          DOI： 10.1038/bjc.1980.178

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  10 in total

1.  Prediction of the response to chemotherapy in acute leukemia.

Authors:  R Zittoun; M Bouchard; J Facquet-Danis; M Percie-du-Sert; J Bousser
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

Review 2.  Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.

Authors:  T C Chou; Z Arlin; B D Clarkson; F S Phillips
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

3.  Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside.

Authors:  M H Tattersall; K Ganeshaguru; A V Hoffbrand
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

4.  Purification and properties of cytidine deaminase from normal and leukemic granulocytes.

Authors:  B A Chabner; D G Johns; C N Coleman; J C Drake; W H Evans
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

Review 5.  Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.

Authors:  H E Skipper; S Perry
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

6.  DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.

Authors:  W Wilmanns
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

7.  Cytidine deaminase and the development of resistance to arabinosyl cytosine.

Authors:  C D Steuart; P J Burke
Journal:  Nat New Biol       Date:  1971-09-22

8.  Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.

Authors:  D H Ho; E Frei
Journal:  Clin Pharmacol Ther       Date:  1971 Nov-Dec       Impact factor: 6.875

9.  Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro.

Authors:  D Kessel; T C Hall; D Rosenthal
Journal:  Cancer Res       Date:  1969-02       Impact factor: 12.701

10.  Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes.

Authors:  C N Coleman; R G Stoller; J C Drake; B A Chabner
Journal:  Blood       Date:  1975-11       Impact factor: 22.113
  10 in total
  1 in total

1.  In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.

Authors:  G J Kaspers; R Pieters; C H Van Zantwijk; P A De Laat; F C De Waal; E R Van Wering; A J Veerman
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.